Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.
Skip to main content
Fig. 3 | BMC Cancer

Fig. 3

From: Clinicopathological characteristics of transcription factor-defined subtypes in bladder small cell carcinoma

Fig. 3

Differential expression of NEUROD1, POU2F3, and synaptophysin in combined bladder small cell carcinoma. (A) H&E, low magnification; (B) NEUROD1, low magnification; (C) POU2F3, low magnification; (D) synaptophysin, low magnification; (E) H&E, high magnification; (F) NEUROD1, high magnification; (G) POU2F3, high magnification; (H) synaptophysin, high magnification. H&E, hematoxylin and eosin. These slides illustrate the mutually exclusive expression patterns of NEUROD1 with synaptophysin or POU2F3 alone. H&E, hematoxylin and eosin

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us